2025-03-26 12:26:33
Latest Post
Gujarat Ambuja Exports Ltd commences commercial production of Greenfield 1200 TPD Maize Processing unit
Wardwizard Promoters take decisive action with Significant Fund Infusion
EaseMyTrip signs MoU with Tourism New Zealand to strengthen travel ties and enhance Indian tourist arrivals
Welspun Corp Limited increases stake in Welspun Specialty Solutions Ltd
Rulka Electricals Secures 21 New Work Orders totaling Rs 12.36 Crore in March 2025
Stock Report
Nath Bio-Genes India Ltd Q2FY23 net profit at Rs. 1.46 crore
Posted On : 2022-10-20 21:09:43( TIMEZONE : IST )
Nath Bio-Genes (India) Limited has reported Standalone financial results for the period ended September 30, 2022.
Financial Results (Q2 FY2023) - QoQ Comparison
The company has reported total income of Rs. 21.9282 crores during the period ended September 30, 2022 as compared to Rs. 209.3897 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs. 1.4693 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 30.7564 crores for the period ended June 30, 2022.
The company has reported EPS of Rs. 0.77 for the period ended September 30, 2022 as compared to Rs. 16.18 for the period ended June 30, 2022.
| Financials | Q2 FY2023 | Q1 FY2023 | % Change |
| Total Income | ₹ 21.9282 crs | ₹209.3897 crs |  -89.53% |
| Net Profit | ₹1.4693 crs | ₹30.7564 crs | -95.22% |
| EPS | ₹0.77 | ₹16.18 | -95.24% |
Financial Results (Q2 FY2023) - YoY Comparison
The company has reported total income of Rs. 21.9282 crores during the period ended September 30, 2022 as compared to Rs.15.2369 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.1.4693 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.1.2306 crores for the period ended September 30, 2021.
The company has reported EPS of Rs.0.77 for the period ended September 30, 2022 as compared to Rs.0.65 for the period ended September 30, 2021.
| Financials | Q2 FY2023 | Q2 FY2022 | % Change |
| Total Income | ₹ 21.9282 crs | ₹15.2369 crs |  43.92% |
| Net Profit | ₹1.4693 crs | ₹1.2306 crs | 19.40% |
| EPS | ₹0.77 | ₹0.65 | 18.46% |
Financial Results (Half Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.231.3178 crores during the 6 Months period ended September 30, 2022 as compared to Rs.230.3398 crores during the 6 Months period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.32.2257 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.46.1422 crores for the 6 Months period ended September 30, 2021.
The company has reported EPS of Rs.16.96 for the 6 Months period ended September 30, 2022 as compared to Rs.24.28 for the 6 Months period ended September 30, 2021.
| Financials | Half Year Ended FY2023 | Half Year Ended FY2022 | % Change |
| Total Income | ₹231.3178 crs | ₹230.3398 crs | 0.42% |
| Net Profit | ₹32.2257 crs | ₹46.1422 crs | -30.16% |
| EPS | ₹16.96 | ₹24.28 | -30.15% |
Shares of Nath Bio-Genes (India) Limited was last trading in BSE at Rs. 168.90 as compared to the previous close of Rs. 159.45. The total number of shares traded during the day was 4248 in over 227 trades.
The stock hit an intraday high of Rs. 169.95 and intraday low of 158.85. The net turnover during the day was Rs. 705484.00.
